Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction

Purpose We assessed the influence of antenatal corticosteroid (ACS) on the inhospital outcomes of intrauterine growth restriction (IUGR) infants. Methods A retrospective study was conducted with singletons born at 23+0 to 33+6 weeks of gestation at Seoul National University Hospital from 2007 to 201...

Full description

Bibliographic Details
Main Authors: Yoo Jinie Kim, Sung Hwan Choi, Sohee Oh, Jin A Sohn, Young Hwa Jung, Seung Han Shin, Chang Won Choi, Ee-Kyung Kim, Han-Suk Kim, Beyong Il Kim, Jin A Lee
Format: Article
Language:English
Published: Korean Society of Neonatology 2018-11-01
Series:Neonatal Medicine
Subjects:
Online Access:http://www.neo-med.org/upload/pdf/nm-2018-25-4-161.pdf
_version_ 1818329533920575488
author Yoo Jinie Kim
Sung Hwan Choi
Sohee Oh
Jin A Sohn
Young Hwa Jung
Seung Han Shin
Chang Won Choi
Ee-Kyung Kim
Han-Suk Kim
Beyong Il Kim
Jin A Lee
author_facet Yoo Jinie Kim
Sung Hwan Choi
Sohee Oh
Jin A Sohn
Young Hwa Jung
Seung Han Shin
Chang Won Choi
Ee-Kyung Kim
Han-Suk Kim
Beyong Il Kim
Jin A Lee
author_sort Yoo Jinie Kim
collection DOAJ
description Purpose We assessed the influence of antenatal corticosteroid (ACS) on the inhospital outcomes of intrauterine growth restriction (IUGR) infants. Methods A retrospective study was conducted with singletons born at 23+0 to 33+6 weeks of gestation at Seoul National University Hospital from 2007 to 2014. We compared clinical outcomes between infants who received ACS 2 to 7 days before birth (complete ACS), at <2 or >7 days (incomplete ACS), and those who did not receive ACS in IUGR and AGA infants. Multivariate logistic regression using Firth’s penalized likelihood was performed. Results 304 neonates with 91 IUGR neonates were eligible. Among AGA neonates, mortality (adjusted odds ratio [aOR], 0.13; 95% confidence interval [CI], 0.02 to 0.78), hypotension within 7 postnatal days (aOR, 0.20; 95% CI, 0.06 to 0.64), and severe bronchopulmonary dysplasia (BPD) or death (aOR, 0.24; 95% CI, 0.07 to 0.77) were lower in complete ACS group after adjusting for pregnancy induced hypertension and uncontrolled preterm labor. Mortality (aOR, 0.18; 95% CI, 0.04 to 0.78), hypotension (aOR, 0.26; 95% CI, 0.09 to 0.70), and severe BPD or death (aOR, 0.33; 95% CI, 0.12 to 0.92) were also lower in the incomplete ACS group. Among IUGR infants, after adjusting for birth weight and 5-minute Apgar score, inhaled nitric oxide use within 14 postnatal days was lower in both complete ACS (aOR, 0.07; 95% CI, 0.01 to 0.67) and incomplete ACS (aOR, 0.04; 95% CI, 0.01 to 0.37) groups. Conclusion ACS was not effective in reducing morbidities in IUGR preterm infants.
first_indexed 2024-12-13T12:49:35Z
format Article
id doaj.art-46448e3f9afe4d8d9efc1ed185b9a8ea
institution Directory Open Access Journal
issn 2287-9412
2287-9803
language English
last_indexed 2024-12-13T12:49:35Z
publishDate 2018-11-01
publisher Korean Society of Neonatology
record_format Article
series Neonatal Medicine
spelling doaj.art-46448e3f9afe4d8d9efc1ed185b9a8ea2022-12-21T23:45:22ZengKorean Society of NeonatologyNeonatal Medicine2287-94122287-98032018-11-0125416116910.5385/nm.2018.25.4.161945Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth RestrictionYoo Jinie Kim0Sung Hwan Choi1Sohee Oh2Jin A Sohn3Young Hwa Jung4Seung Han Shin5Chang Won Choi6Ee-Kyung Kim7Han-Suk Kim8Beyong Il Kim9Jin A Lee10 Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Department of Biostatistics, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine, Seoul, KoreaPurpose We assessed the influence of antenatal corticosteroid (ACS) on the inhospital outcomes of intrauterine growth restriction (IUGR) infants. Methods A retrospective study was conducted with singletons born at 23+0 to 33+6 weeks of gestation at Seoul National University Hospital from 2007 to 2014. We compared clinical outcomes between infants who received ACS 2 to 7 days before birth (complete ACS), at <2 or >7 days (incomplete ACS), and those who did not receive ACS in IUGR and AGA infants. Multivariate logistic regression using Firth’s penalized likelihood was performed. Results 304 neonates with 91 IUGR neonates were eligible. Among AGA neonates, mortality (adjusted odds ratio [aOR], 0.13; 95% confidence interval [CI], 0.02 to 0.78), hypotension within 7 postnatal days (aOR, 0.20; 95% CI, 0.06 to 0.64), and severe bronchopulmonary dysplasia (BPD) or death (aOR, 0.24; 95% CI, 0.07 to 0.77) were lower in complete ACS group after adjusting for pregnancy induced hypertension and uncontrolled preterm labor. Mortality (aOR, 0.18; 95% CI, 0.04 to 0.78), hypotension (aOR, 0.26; 95% CI, 0.09 to 0.70), and severe BPD or death (aOR, 0.33; 95% CI, 0.12 to 0.92) were also lower in the incomplete ACS group. Among IUGR infants, after adjusting for birth weight and 5-minute Apgar score, inhaled nitric oxide use within 14 postnatal days was lower in both complete ACS (aOR, 0.07; 95% CI, 0.01 to 0.67) and incomplete ACS (aOR, 0.04; 95% CI, 0.01 to 0.37) groups. Conclusion ACS was not effective in reducing morbidities in IUGR preterm infants.http://www.neo-med.org/upload/pdf/nm-2018-25-4-161.pdfprenatal caresteroidsfetal growth retardationpremature infantoutcome assessment (health care)
spellingShingle Yoo Jinie Kim
Sung Hwan Choi
Sohee Oh
Jin A Sohn
Young Hwa Jung
Seung Han Shin
Chang Won Choi
Ee-Kyung Kim
Han-Suk Kim
Beyong Il Kim
Jin A Lee
Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction
Neonatal Medicine
prenatal care
steroids
fetal growth retardation
premature infant
outcome assessment (health care)
title Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction
title_full Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction
title_fullStr Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction
title_full_unstemmed Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction
title_short Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction
title_sort antenatal corticosteroids and clinical outcomes of preterm singleton neonates with intrauterine growth restriction
topic prenatal care
steroids
fetal growth retardation
premature infant
outcome assessment (health care)
url http://www.neo-med.org/upload/pdf/nm-2018-25-4-161.pdf
work_keys_str_mv AT yoojiniekim antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT sunghwanchoi antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT soheeoh antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT jinasohn antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT younghwajung antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT seunghanshin antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT changwonchoi antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT eekyungkim antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT hansukkim antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT beyongilkim antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction
AT jinalee antenatalcorticosteroidsandclinicaloutcomesofpretermsingletonneonateswithintrauterinegrowthrestriction